latest update:
[RxAtlas]

Sources · every licence documented

RxAtlas compiles from 13 active sources: public regulators, research bodies, and structured registries. Each one below carries its own licence and redistribution terms. 13 are marked commercial-use cleared in the manifest and can ship values in the API, MCP tools, and downloadable snapshots; the rest, if any, are listed for provenance or licence review.

Attribution is per-value, not per-dataset. Every field in the API response and every row in a snapshot carries its own source citation, so attribution travels with the value even when a single record blends multiple sources. The live registry is also available at GET https://api.rxatlas.dev/v1/sources, and every snapshot ships a LICENSE-NOTES.md with the full per-source licence and attribution text. See /docs/data-dictionary for the provenance model.

Commercial-use cleared sources

13 sources

Sources cleared in the manifest for commercial dataset redistribution and buyer-facing exports.

SourceJurisdictionLicenceRedistributed
cms-sdud

State and national aggregate Medicaid utilization facts at utilization-type, exact NDC11, year, and quarter grain; suppressed measures remain null and reimbursement is not represented as price or coverage.

United StatesPublic Domain Mark 1.0yes
dailymed

Structured Product Label titles, versions, and publication dates joined to the SPL set identifiers carried by FDA product records.

United StatesUS Public Domain (NLM)yes
drugsfda

FDA application, product-number, submission, and document-metadata records delivered as separate auxiliary tables without claiming product-number-to-NDC applicability.

United StatesPublic Domain and CC0yes
fda-iid

Quarterly FDA inactive-ingredient potency and maximum-daily-exposure facts delivered at ingredient/route/dosage-form grain; CAS Registry Numbers are excluded and product applicability is not asserted.

United StatesUS Public Domain (CAS Registry Numbers excluded)yes
orange-book

FDA application, approval-date, dosage-form, route, and marketing facts associated without using application numbers as product identity.

United StatesUS Public Domainyes
fda-pmr-pmc

Quarterly FDA postmarketing requirements and commitments delivered as a separate application/submission/obligation-grain auxiliary table; product-NDC applicability is not asserted.

United StatesUS Public Domainyes
fda-rems

REMS program, version, and application-association records delivered as separate auxiliary tables; unreliable historical active flags, REMS goals, linked materials, and product-NDC applicability are excluded.

United StatesUS Public Domainyes
nadac

Latest-effective CMS Medicaid NADAC per-unit observations linked only to held product or package NDCs.

United StatesUS Public Domainyes
openfda-shortages

Current openFDA shortage-feed observations attached to the product spine through exact source package NDCs and retained at observation grain.

United StatesCC0 1.0yes
openfda-enforcement

FDA drug enforcement records associated to product rows through exact source-reported NDC values.

United StatesCC0 1.0yes
openfda-ndc

FDA product and package NDC records from the official openFDA bulk export.

United StatesCC0 1.0yes
openfda-unii

UNII-to-substance-name records joined only to exact product-to-UNII associations carried by the separately versioned openFDA NDC bulk feed.

United StatesCC0 1.0yes
rxnorm

Redistributable RxNorm and MTHSPL normalized names joined from NLM's bulk mapping archive to exact product-to-RxCUI associations carried by the FDA product feed.

United StatesRxNorm (RXNORM/MTHSPL subset, redistributable)yes

Related evaluation guides

Connect this diligence evidence to the relevant integration decision.